AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06116773 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Patients will be informed about secondary prevention approaches which is routinely performed after discharge after CABG operation and will be recommended a home-based exercise program. Patients will be called by phone once a week and exercise monitoring will be provided. Recommended home exercise program includes:~* Breathing exercises~* Moderate intensity (RPE 4-6) walking (150 min/week).~* Posture exercises (shoulder elevation-depression, 90 degree shoulder flex-extend, 90 degree shoulder abd-add, neck joint range of motion exercises)~* They will be advised to continue range of motion exercises in the early post-operative period. (Twice a day, 10 repetitions).These exercises include ankle dorsi-plantar flexion, hip abduction-adduction, hip internal-external rotation, hip flexion-extension, arm elevation-depression in the supine position; flexion-extension in the sitting position; hip abduction-adduction, hip hyperextension and counting movements in the standing position.
Study NCT05487924 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SVV-GDHT
Description: GDHT guided by SVV using Flotra/Vigileo monitor
Study NCT05487924 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: O2ER-GDHT
Description: GDHT guided by O2ER
Study NCT05487924 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional care
Description: conventional fluid therapy without GDHT
Study NCT05148000 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: QM1114-DP
Description: QM1114-DP
Study NCT05075317 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard cardiac rehabilitation
Description: Standard, multi-dimensional cardiac rehabilitation program.
Study NCT05075317 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard cardiac rehabilitation
Description: Standard, multi-dimensional cardiac rehabilitation program.
Study NCT05075317 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Time-Restricted Eating
Description: Counselling to restrict their eating to between 11 am and 7 pm and to consume water-only for the remaining 16 hours per day
Study NCT05785754 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab injection
Study NCT05836038 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Visio-Tactile Stimulation
Description: They will see their virtual hand touched while simultaneously feel their opposite real hand touched in the same pattern.
Study NCT06573632 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: TPN-N7 Baxter
Description: providing TPN to all malnutrition patients preoperatively as well as postoperatively.
Study NCT05425823 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Belief Model Based Intervention
Description: In intervention group-1, Information Form and PAVS-HBM will be applied as a pre-test to pregnant women who have completed their 28th gestational week. Childhood Vaccination Training Based on the Health Belief Model will be given in the prenatal period by organizing 2 face-to-face and individual sessions for the researcher's pregnant women. Each session will take approximately 30-45 minutes, with each session being in a different week. In addition, at the end of each session, HBM-based short messages will be sent to the pregnant woman's husband and recorded with the Short Message Tracking Form. Intervention group-2 will receive the same training, but no text messages will be sent.
Study NCT05348018 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Playing Serious Games during a four-week test period in addition to conventional lectures
Description: Playing SGs during a four-week test period in addition to conventional lectures in oral rehabilitation
Study NCT05519267 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MBSWSC
Description: MBSWSC is a unique mindfulness-based programme for social work and self-care which has been specifically developed for online delivery. The MBSWSC programme is embedded within key cognitive and emotion regulation, and stress coping theory (Maddock et al. 2019a). This programme combines mindfulness practices with psychoeducation with the aim of allowing participants to reduce any negative thinking about the past and future by learning skills that will allow them to focus on the present. It will also focus on how to effectively apply these newly acquired mindfulness skills in social work practice. The MBSWSC programme comprises 6x1.5 hour sessions, delivered weekly, over a 6 week period. Homework, in the form of mindfulness practices, is given each week. This will take approximately 20-30 minutes to complete, on 6 out of 7 days, each week.
Study NCT05519267 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: MBSC
Description: MBSC is a modified, condensed Mindfulness Based Intervention; with a key focus on self-compassion. Key practices in this condensed programme were chosen for their relevance and utility to social workers. The MBSC programme comprises 3x1 hour sessions delivered over a 6 week period, with one session every two weeks. Homework, in the form of mindfulness practices, is given each week. This will take approximately 20-30 minutes to complete, on 6 out of 7 days, each week.
Study NCT05606913 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dulaglutide
Description: Dulaglutide administered subcutaneously (SC) once a week.
Study NCT05606913 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI362
Description: IBI362 administered subcutaneously (SC) once a week.
Study NCT05288842 — intervention group
Intervention type: BIOLOGICAL
Intervention: Lumbar puncture
Description: 5 mL of CSF
Study NCT05288842 — intervention group
Intervention type: BIOLOGICAL
Intervention: blood sample
Description: 6x5 mL of blood sample collected :1 dry tube, 2 EDTA tubes, 1 fluoride tube, and 2 polypropylene tubes
Study NCT05810974 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Concentrated beetroot juice
Description: Subjects will consume 70ml shot (Beet-it Sport nitrate 400 shot, James White Drinks) and this drink contains 0.4g inorganic nitrate
Study NCT05810974 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Nitrate depleted beetroot juice + potassium nitrate (KNO3)
Description: Nitrate-depleted beetroot juice (70ml) and 0.4g KNO3- will be mixed. (Same appearance and taste with Beet-it sport shot)
Study NCT05810974 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Nitrate depleted beetroot juice
Description: Subjects will consume 70ml of (Beet-it Placebo shot, James White Drinks). This drink is the same as the Beet-it Sport nitrate shot but has the nitrate removed.
Study NCT05818332 — intervention group
Intervention type: OTHER
Intervention: Observational study
Description: No intervention, observational only
Study NCT05633901 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Educational Video
Description: Patients will be given the link to the educational video and able to view it as many times as they want
Study NCT05633901 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard Counseling
Description: Current standard of care verbal counseling from a clinic nurse
Study NCT05637151 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: clamp time of umbilical
Description: The umbilical cord was clamped immediately or late for more than 30s
Study NCT06096116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Human plasma derived antithrombin
Description: A solvent/detergent and heat-treated antithrombin concentrate derived from human plasma
Study NCT06096116 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Half of the patients in the placebo group will be randomised to receive a volume of placebo corresponding to the low dose of Atenativ and the other half to receive a volume of placebo corresponding to a high dose of Atenativ
Study NCT05637151 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: clamp time of umbilical
Description: The umbilical cord was clamped immediately or late for more than 30s
Study NCT05689632 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D3 + K2-MK7
Description: Combined supplementation
Study NCT05689632 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: MCT
Study NCT05689632 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3
Description: Vitamin D3 - 7000 IU
Study NCT06065475 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral Thyroid Cartilage Plane Block
Description: Use a SonoSite high-frequency linear array transducer (5-13 MHz, SonoSite, USA). Place the transducer parallel to the spine on one side of the neck, ensuring clear visualization of the thyroid cartilage plate under ultrasound. Employ ultrasound-guided out-of-plane techniques to display the needle insertion path and tip. Once the needle tip contacts the upper half of the thyroid cartilage plate, injecting 2.5ml of 2% lidocaine on the surface of the thyroid cartilage each side.
Study NCT05924646 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sodium Chloride Capsules
Description: Table salt in slow release capsules.
Study NCT06498557 — intervention group
Intervention type: OTHER
Intervention: Peripheral nerve block methods
Description: We apply different nerve blocks to patients for analgesic purposes after knee replacement surgery. These blocks are a combination of SFIP block and adductor channel block and iPACK block.
Study NCT05924646 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Microcystalline Cellulose Capsules
Description: Microcrystalline Cellulose Capsules (Placebo)
Study NCT05230329 — intervention group
Intervention type: PROCEDURE
Intervention: right sided hemicolectomy, laparoscopy
Description: Comparison of CME
Study NCT05042453 — intervention group
Intervention type: DEVICE
Intervention: Splentis® POP Tissue Anchoring System
Description: Anterior cervicopexy with bilateral sacrospinous ligament fixation using Splentis
Study NCT06229379 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Digital twin patient
Description: Digital twin patient can serve as patients with specific diseases for medical students to acquire disease history and thus practice clinical questioning skills.
Study NCT06229379 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Digital twin patient
Description: Digital twin patient can serve as patients with specific diseases for medical students to acquire disease history and thus practice clinical questioning skills.
Study NCT06257147 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: multifaceted antibiotic stewardship intervention
Description: Group 3 wards will receive a multifaceted antibiotic stewardship intervention. Physician education will be provided as in Group 1. All consecutive patients fulfilling inclusion and exclusion criteria for study eligibility will be assessed by an Antibiotic Stewardship team. A trained nurse will first assess the patients for clinical and host criteria to determine eligibility for short-course antibiotic therapy. The antibiotic susceptibility test results and the prescribed antibiotics treatment will be reviewed. An Infectious Diseases physician will subsequently make written recommendations for the duration and choice of antibiotic therapy, and provide an appointment within 2 weeks after hospital discharge to review patients' clinical condition when indicated.
Study NCT06257147 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: multifaceted antibiotic stewardship intervention
Description: Group 3 wards will receive a multifaceted antibiotic stewardship intervention. Physician education will be provided as in Group 1. All consecutive patients fulfilling inclusion and exclusion criteria for study eligibility will be assessed by an Antibiotic Stewardship team. A trained nurse will first assess the patients for clinical and host criteria to determine eligibility for short-course antibiotic therapy. The antibiotic susceptibility test results and the prescribed antibiotics treatment will be reviewed. An Infectious Diseases physician will subsequently make written recommendations for the duration and choice of antibiotic therapy, and provide an appointment within 2 weeks after hospital discharge to review patients' clinical condition when indicated.
Study NCT05309512 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KN052
Description: 0.01mg/kg, 0.1mg/kg, 0.3mg/kg, 1mg/kg, 2mg/kg, 4mg/kg, 6mg/kg, 9mg/kg, RP2D once every two or three weeks intravenously
Study NCT06046534 — intervention group
Intervention type: OTHER
Intervention: None (Observational study)
Description: Not applicable since this is observational study.
Study NCT05904600 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Respiratory muscle training
Description: The training of the intervention group will have an initial workload of 30% of maximal inspiratory and expiratory pressures, which will be increased weekly by 10% according to tolerance, if not tolerated by 5%. In addition, patients will be instructed to maintain a normal respiratory rate (12-16 breaths per minute). Moreover, they will continue their usual treatment.
Study NCT05904600 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Control group
Description: In the control group, the respiratory muscle training will be simulated by using the device without load throughout the study period using an opaque adhesive tape surrounding the device to mask the valve position.
Study NCT04943926 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Energy restricted diet
Description: Nutritional complete formula diet followed by an energy restricted diet
Study NCT04943926 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low carbohydrate high fat diet
Description: Very low-carbohydrate high-fat ketogenic diet (VLCHF) diet followed by a low-carbohydrate high-fat diet (LCHF)
Study NCT06229379 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Interaction with real patients
Description: As in traditional medical education, medical students need to interact with real patients to practice history collection skills.
Study NCT00900991 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: split-virion pandemic influenza vaccine (H5N1 strain NIBRG-14)
Study NCT05871853 — intervention group
Intervention type: BEHAVIORAL
Intervention: Improved breastfeeding support
Description: Cross-sectoral intervention to improve breastfeeding support among women giving birth at Slagelse Hospital, Region Zealand, Denmark
Study NCT06274385 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Betalain-rich concentrate (AltRed)
Description: A single dose of 100 mg (2 x 50 mg) 120 min before exhaustive exercise.~Supplement instructions:~All treatments will be administered in similar capsules (smell, color, and size) to ensure both the participants and researcher are blinded to the treatment. All treatments will be administered in an opaque lidded container.~The participants will be instructed to close their eyes and carefully open the container, keeping their heads forward. They will be asked to place the container to their lips, tipping the container to pour the contents into their mouth. Immediately after, they will be instructed to drink water to help them swallow the pill and instructed not to chew or manipulate the pill inside their mouth.
Study NCT06274385 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A single dose (2 x empty capsules) 120 min before exhaustive exercise.~Supplement instructions:~All treatments will be administered in similar capsules (smell, color, and size) to ensure both the participants and researcher are blinded to the treatment. All treatments will be administered in an opaque lidded container.~The participants will be instructed to close their eyes and carefully open the container, keeping their heads forward. They will be asked to place the container to their lips, tipping the container to pour the contents into their mouth. Immediately after, they will be instructed to drink water to help them swallow the pill and instructed not to chew or manipulate the pill inside their mouth.
Study NCT05188807 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Airway ultrasonography
Description: we will measure hyomental distance, skin-epiglottis distance, skin-hyoid distance, epiglottis-vocalcords distance
Study NCT05688670 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Regional Anesthesia
Description: Bilateral pecto-intercostal fascial plane block (PIFB) and unilateral rectus sheath block (RSB) with Ropivacaine 0.2%
Study NCT05688670 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Wound infiltration
Description: Surgeon-delivered wound infiltration with Ropivacaine 0.2%
Study NCT05688670 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine 0.2% Injectable Solution
Description: Ropivacaine 1.5 mL/kg will be used for both interventions
Study NCT05919329 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Piflufolastat
Description: Given IV
Study NCT06411964 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Prebiotic
Description: Commercially available supplement (Bimuno)
Study NCT06411964 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo control
Description: maltodextrin control supplement
Study NCT05486039 — intervention group
Intervention type: BEHAVIORAL
Intervention: Changing behaviour
Description: Changing the lying position and mattress system
Study NCT06572878 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive training
Description: Cognitive training will follow a group format, with each group consisting of 4-16 participants. Each group will be in a private, independent room for their training sessions and will not interact with participants from other groups. The cognitive training task components will specifically focus on attention, learning and memory, executive function, perceptual-motor skills, and language.
Study NCT06572878 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical training
Description: Physical training will follow a group format, with each group consisting of 4-16 participants. Each group will be in a private, independent room for their training sessions and will not interact with participants from other groups. The physical training task components will specifically focus on strength, balance, agility, gait, low-volume aerobic, and flexibility.
Study NCT06572878 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined cognitive and physical training
Description: Combined cognitive and physical training will follow a group format, with each group consisting of 4-16 participants. Each group will be in a private, independent room for their training sessions and will not interact with participants from other groups. The combined cognitive and physical training components will specifically focus on a single cognitive task and simultaneously handle a single physical task.
Study NCT06572878 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Passive information activities
Description: In passive informational activities, which include a variety of puzzles, audiobooks, and diverse reading materials such as newspapers or listening to news content.
Study NCT04894435 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: mRNA-1273 SARS-CoV-2 vaccine
Description: Contains 1.26 mg of CX-024414 mRNA and 24.38 mg of SM-102 LNP as a white to off-white dispersion in preservative-free diluent buffer at pH 7.5.
Study NCT04894435 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: BNT162b2
Description: A white to off-white, sterile, preservative-free, frozen suspension for intramuscular injection, supplied with 0.9% sodium chloride diluent for injection plastic ampoules.
Study NCT04894435 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ChAdOx1-S [recombinant]
Description: A colourless to slightly brown, clear to slightly opaque solution containing 5 x 1010 viral particles (not less than 2.5 x 108 infectious units).
Study NCT04894435 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 0, 28 day schedule
Description: Second injection administered 28 days post first injection
Study NCT04894435 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 0, 112 day schedule
Description: Second injection administered 112 days post first injection
Study NCT04894435 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Covifenz
Description: COVIFENZ is an emulsion for intramuscular injection. The 3.75 mcg antigen component of COVIFENZ is a suspension, which must be mixed 1:1 with the 0.25 mL AS03 adjuvant emulsion component prior to administration
Study NCT04894435 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Covifenz
Description: COVIFENZ is an emulsion for intramuscular injection. The 3.75 mcg antigen component of COVIFENZ is a suspension, which must be mixed 1:1 with the 0.25 mL AS03 adjuvant emulsion component prior to administration